comparemela.com

Latest Breaking News On - Carla benigni - Page 1 : comparemela.com

Alpheus Medical Treats First Patients in First-In-Human Clinical Trial for Novel High-Grade Glioma Brain Cancer Treatment

Milestone arrives as the company closes a $14 million follow-on Series A financing round to expand the clinical program for high-grade gliomas, in.

New yorkUnited statesCarla benigniVijay agarwalPrnewswire alpheusMichael schulderTannerm johannsMedtech convergence fundSv health investorsBrain tumor investment fundNorthwell health north shore university hospitalDent neurologic institute buffaloAlpheus medical incNational brain tumor societyWashington university in stAmerican cancer society

Endotronix, Inc : Endotronix Celebrates 400th Implant of Cordella Pulmonary Artery Pressure Sensor for Proactive, Remote Heart Failure Management

Company also announces publication of the PROACTIVE-HF trial design rationale, the first global IDE trial for PA pressure-guided heart failure management, in the Journal of Cardiac Failure LISLE

Carla benigniKostenloser wertpapierhandelLiviu kleinHarry rowlandPrnewswire endotronix incYork heart associationEndotronix incNational principal investigatorUniversity of california san franciscoCordella pulmonary arteryCordella pulmonary artery pressureCordella heart failure systemCordella systemSection chiefAdvanced heart failureMechanical circulatory support

Endotronix Celebrates 400th Implant of Cordella™ Pulmonary Artery Pressure Sensor for Proactive, Remote Heart Failure Management

/PRNewswire/ Endotronix, Inc., a privately-held digital health and medical technology company dedicated to advancing the treatment of heart failure (HF),.

Carla benigniLiviu kleinHarry rowlandPrnewswire endotronix incYork heart associationEndotronix incNational principal investigatorUniversity of california san franciscoPulmonary arteryCordella heart failure systemCordella systemSection chiefAdvanced heart failureMechanical circulatory supportPulmonary hypertensionHeart transplant

Endotronix Celebrates 400th Implant of Cordella™ Pulmonary Artery Pressure Sensor for Proactive, Remote Heart Failure Management

Company also announces publication of the PROACTIVE-HF trial design rationale, the first global IDE trial for PA pressure-guided heart failure man.

Carla benigniLiviu kleinHarry rowlandPrnewswire endotronix incYork heart associationEndotronix incNational principal investigatorUniversity of california san franciscoPulmonary arteryPulmonary artery pressureCordella heart failure systemCordella systemSection chiefAdvanced heart failureMechanical circulatory supportPulmonary hypertension

Endotronix Celebrates 400th Implant of Cordella™ Pulmonary Artery Pressure Sensor for Proactive, Remote Heart Failure Management

/PRNewswire/ Endotronix, Inc., a privately-held digital health and medical technology company dedicated to advancing the treatment of heart failure (HF),.

Carla benigniLiviu kleinHarry rowlandPrnewswire endotronix incYork heart associationEndotronix incNational principal investigatorUniversity of california san franciscoPulmonary arteryCordella heart failure systemCordella systemSection chiefAdvanced heart failureMechanical circulatory supportPulmonary hypertensionHeart transplant

vimarsana © 2020. All Rights Reserved.